Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China
· Delayed Price · Currency is CNY 7.09
-0.02 (-0.28%)
Apr 29, 2026, 3:04 PM CST
SHE:002550 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 8,861 | 9,823 | 7,749 | 7,525 | 8,012 | 6,181 | Upgrade
|
| Market Cap Growth | 17.00% | 26.77% | 2.97% | -6.07% | 29.61% | 13.64% | Upgrade
|
| Enterprise Value | 7,580 | 8,782 | 7,071 | 7,054 | 7,540 | 5,582 | Upgrade
|
| Last Close Price | 7.09 | 7.86 | 6.09 | 5.66 | 5.90 | 4.45 | Upgrade
|
| PE Ratio | 27.39 | 24.63 | 21.76 | 41.38 | 24.77 | 34.14 | Upgrade
|
| Forward PE | - | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | Upgrade
|
| PS Ratio | 5.99 | 6.25 | 5.08 | 4.15 | 3.48 | 3.30 | Upgrade
|
| PB Ratio | 3.11 | 3.55 | 3.08 | 3.04 | 3.29 | 2.92 | Upgrade
|
| P/TBV Ratio | 3.24 | 3.71 | 3.23 | 3.23 | 3.43 | 3.08 | Upgrade
|
| P/FCF Ratio | 33.88 | 44.70 | 18.27 | 17.38 | - | 468.80 | Upgrade
|
| P/OCF Ratio | 20.70 | 27.18 | 15.06 | 14.11 | - | 59.69 | Upgrade
|
| EV/Sales Ratio | 5.13 | 5.59 | 4.63 | 3.89 | 3.27 | 2.98 | Upgrade
|
| EV/EBITDA Ratio | 20.00 | 22.05 | 20.39 | 30.49 | 26.24 | 25.17 | Upgrade
|
| EV/EBIT Ratio | 24.42 | 26.41 | 25.06 | 43.50 | 33.88 | 36.63 | Upgrade
|
| EV/FCF Ratio | 28.99 | 39.96 | 16.68 | 16.29 | - | 423.36 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.06 | 0.24 | 0.36 | 0.42 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | 0.05 | 0.13 | - | 7.10 | Upgrade
|
| Net Debt / Equity Ratio | -0.45 | -0.39 | -0.35 | -0.27 | -0.15 | -0.28 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.40 | -2.72 | -2.55 | -2.84 | -1.30 | -2.67 | Upgrade
|
| Net Debt / FCF Ratio | -4.89 | -4.92 | -2.09 | -1.52 | 2.62 | -44.93 | Upgrade
|
| Asset Turnover | 0.48 | 0.53 | 0.55 | 0.65 | 0.87 | 0.76 | Upgrade
|
| Inventory Turnover | 1.53 | 1.64 | 1.35 | 1.84 | 3.03 | 2.92 | Upgrade
|
| Quick Ratio | 5.56 | 6.22 | 5.39 | 4.89 | 4.00 | 3.83 | Upgrade
|
| Current Ratio | 7.30 | 8.47 | 7.58 | 7.90 | 6.07 | 5.30 | Upgrade
|
| Return on Equity (ROE) | 10.86% | 14.13% | 13.35% | 7.28% | 14.06% | 8.91% | Upgrade
|
| Return on Assets (ROA) | 6.28% | 7.02% | 6.30% | 3.64% | 5.24% | 3.84% | Upgrade
|
| Return on Invested Capital (ROIC) | 15.63% | 16.63% | 13.77% | 7.34% | 11.02% | 9.41% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.50% | 11.60% | 10.80% | 6.30% | 8.80% | 6.90% | Upgrade
|
| Earnings Yield | 3.64% | 4.06% | 4.59% | 2.42% | 4.04% | 2.93% | Upgrade
|
| FCF Yield | 2.95% | 2.24% | 5.47% | 5.75% | -1.78% | 0.21% | Upgrade
|
| Dividend Yield | 1.69% | - | 1.97% | 2.12% | 2.04% | 2.70% | Upgrade
|
| Payout Ratio | 46.38% | 37.72% | 42.56% | 87.31% | 47.98% | 83.67% | Upgrade
|
| Buyback Yield / Dilution | 1.72% | 1.99% | 2.11% | -0.41% | -7.16% | -0.58% | Upgrade
|
| Total Shareholder Return | 3.39% | 1.99% | 4.08% | 1.71% | -5.13% | 2.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.